Status:
COMPLETED
Exploring Long-term Risks and STI Prevalence in Pre-Exposure Prophylaxis Users in Gironde, France
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
HIV Infections
Sexually Transmitted Diseases
Eligibility:
All Genders
18+ years
Brief Summary
SAFER-PrEP investigates the long-term impact of Pre-Exposure Prophylaxis (PrEP) on risky sexual behaviors and Sexually Transmitted Infection (STI) prevalence among users in Aquitaine. The study aims t...
Detailed Description
Scientific Rationale: The SAFER-PrEP study stems from the imperative to comprehend the intricate interplay between Pre-Exposure Prophylaxis (PrEP) utilization and sexual health dynamics. Amidst the in...
Eligibility Criteria
Inclusion
- Aged over 18 years old;
- Participants using PrEP for at least 6 months ;
- French-speaking, without comprehension disorders ;
- being affiliated to health insurance ;
- Willing to participate and to sign informed consent.
Exclusion
- Individuals with known HIV positivity;
Key Trial Info
Start Date :
November 4 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 3 2025
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT06600087
Start Date
November 4 2024
End Date
June 3 2025
Last Update
September 5 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Cegidd de Bordeaux
Bordeaux, France
2
CHU de Bordeaux - Service de médecine interne et maladies infectieuses
Bordeaux, France
3
Maison de la Santé de l'Hôpital Saint-André - Médecine Générale
Bordeaux, France
4
Cabinet de Medecine Generale
Fargues-Saint-Hilaire, France